narcan naloxone hci

Generic: narcan naloxone hci

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name narcan naloxone hci
Generic Name narcan naloxone hci
Labeler hf acquisition co llc, dba healthfirst
Dosage Form SPRAY
Routes
NASAL
Active Ingredients

naloxone hydrochloride 4 mg/.1mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1240
Product ID 51662-1240_07627f49-62b7-7d91-e063-6294a90a796d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA208411
Listing Expiration 2026-12-31
Marketing Start 2018-10-15

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621240
Hyphenated Format 51662-1240

Supplemental Identifiers

RxCUI
1725059
UPC
0369547353025
UNII
F850569PQR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name narcan naloxone hci (source: ndc)
Generic Name narcan naloxone hci (source: ndc)
Application Number NDA208411 (source: ndc)
Routes
NASAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/.1mL
source: ndc
Packaging
  • .1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1)
  • 2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2) / .1 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

51662-1240-1 .1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1) 51662-1240-2 2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2) / .1 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

naloxone hydrochloride (4 mg/.1mL)

Linked Drug Pages (1)

NARCAN NALOXONE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "07627f49-62b7-7d91-e063-6294a90a796d", "openfda": {"upc": ["0369547353025"], "unii": ["F850569PQR"], "rxcui": ["1725059"], "spl_set_id": ["784a0e98-c2d6-f845-e053-2991aa0ac4b4"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": ".1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1)", "package_ndc": "51662-1240-1", "marketing_start_date": "20181015"}, {"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2)  / .1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1240-2", "marketing_start_date": "20181015"}], "brand_name": "NARCAN NALOXONE HCI", "product_id": "51662-1240_07627f49-62b7-7d91-e063-6294a90a796d", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1240", "generic_name": "NARCAN NALOXONE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NARCAN NALOXONE HCI", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.1mL"}], "application_number": "NDA208411", "marketing_category": "NDA", "marketing_start_date": "20181015", "listing_expiration_date": "20261231"}